BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:26 PM
Nov 05, 2009
 |  BC Extra  |  Company News

NICE rebuffs Nplate

The U.K.'s NICE issued a preliminary appraisal recommending against the use of Nplate romiplostim from Amgen Inc. (NASDAQ:AMGN) to treat chronic idiopathic thrombocytopenic purpura....

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >